However, combined PI3K and BET inhibition induced cell death, tumor regression and dampened inhibition of PI3K signaling in metastatic breast cancer cell lines as well as in ovarian, colorectal, GBM and prostate cancer cell lines, indicating a strategy for circumventing resistance to kinase inhibitor therapy [93] (Table 3). Here, DNER is linked to neoplasm.